|
Venus Remedies Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
870.79 Cr.
|
P/BV
|
1.40
|
Book Value (Rs.)
|
463.74
|
|
52 Week High/Low (Rs.)
|
840/278
|
FV/ML
|
10/1
|
P/E(X)
|
19.22
|
|
Bookclosure
|
23/09/2024
|
EPS (Rs.)
|
33.90
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 647.29 | 591.45 | 553.38 | 598.65 | 540.50 |
| Other Operating Revenues | 0.60 | 10.00 | 2.13 | 0.00 | 7.62 |
| Total Operating Revenues | 647.89 | 601.45 | 555.51 | 598.65 | 548.12 |
| | | | | | |
| Other Income | 20.96 | 11.58 | 10.32 | 8.31 | 19.63 |
| Total Revenue | 668.84 | 613.03 | 565.83 | 606.96 | 567.75 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 348.77 | 344.28 | 317.79 | 381.97 | 347.94 |
| Purchase Of Stock-In Trade | 25.04 | 13.07 | 5.16 | 0.00 | 0.00 |
| Operating And Direct Expenses | 23.57 | 18.50 | 14.37 | 12.78 | 11.16 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 4.81 | -2.66 | 8.04 | 3.48 | -7.15 |
| Employee Benefit Expenses | 80.49 | 71.50 | 61.33 | 52.33 | 46.02 |
| Finance Costs | 0.07 | 0.09 | 0.29 | 0.48 | 13.02 |
| Depreciation And Amortisation Expenses | 22.51 | 26.44 | 32.30 | 33.53 | 35.28 |
| Other Expenses | 101.68 | 97.15 | 88.62 | 85.97 | 96.37 |
| Total Expenses | 606.93 | 568.39 | 527.90 | 570.55 | 542.64 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 61.91 | 44.64 | 37.93 | 36.41 | 25.11 |
| | | | | | |
| Exceptional Items | 9.91 | 0.00 | 0.00 | 0.00 | 23.44 |
| Profit/Loss Before Tax | 71.83 | 44.64 | 37.93 | 36.41 | 48.55 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 18.93 | 11.74 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.65 | 3.93 | 11.36 | -4.32 | -13.21 |
| Tax For Earlier Years | 2.93 | 0.48 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | 26.51 | 16.15 | 11.36 | -4.32 | -13.21 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 45.31 | 28.49 | 26.57 | 40.72 | 61.77 |
| | | | | | |
| Profit/Loss From Continuing Operations | 45.31 | 28.49 | 26.57 | 40.72 | 61.77 |
| | | | | | |
| Profit/Loss For The Period | 45.31 | 28.49 | 26.57 | 40.72 | 61.77 |
| Consolidated Profit/Loss After MI And Associates | 45.31 | 28.49 | 26.57 | 40.72 | 61.77 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 33.90 | 21.31 | 19.88 | 30.86 | 50.04 |
| Diluted EPS (Rs.) | 33.90 | 21.31 | 19.88 | 30.86 | 50.04 |
